Dow Corning to Present on Improving Compliance with Innovative Silicone-Based Drug Delivery Systems

Dow Corning will address the need for improved efficacy and patient compliance at the forthcoming CPhl Worldwide and the Speakers Corner Lecture at the tradeshow. Myriam Delvaux, Global Pharma Market Leader, will present "Improving efficacy and compliance: Innovative silicone-based topical and transdermal drug delivery systems."

Delvaux said: "Increasing costs of health care are driving payers to demand outcome-based solutions – increasing the need for improved efficacy and patient compliance in the delivery of pharmaceuticals."

In the talk Dow Corning will outline:

  • How silicone-based solutions can help provide superior drug delivery profiles
  • How enhanced treatment efficacy and product aesthetics can lead to better patient compliance
  • How new APIs designed for manufacturing of aqueous based pharmaceuticals can lead to more convenient forms in gastroenterology.

Additional product information and exhibits will be available on the booth where Dow Corning experts will be on hand to share their knowledge and perspective. They will explain the company's proven capabilities with a view to future collaboration for the potential creation of optimal drug delivery systems for the controlled release of active pharmaceutical ingredients.

"With more than 60 years experience of advancing healthcare through materials innovation, Dow Corning® silicones have a proven history of being able to effectively load, stabilize and release actives from a variety of matrices. Our specialist expertise and the solutions we present will demonstrate how silicones can address crucial drug delivery challenges and help to make sure that patients can be treated with new and appealing materials in a cost efficient manner," said Delvaux.

CPhI Worldwide, 22-24 October 2014 in Frankfurt/Germany: Dow Corning at booth 31B06: http://www.cphi.com/

Schedule time with Dow Corning experts at the CPhI Worldwide exhibition: javascript:ContactUsPopupExtraQueryString ('http://www.dowcorning.com','HCCPHI13','','',%20'')

Attend our lecture presentation on Tue, 22nd October at 13:30 p.m. – at the CPhI speakers corner #FOB02: http://www.cphi.com/es/europe/networking/free-seminars

Read the Interview with Myriam Delvaux, Global Pharma Market Leader: http://www.cphi.com/europe/5-minutes-with-myriam-delvaux

Source: http://www.dowcorning.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dow Corning. (2019, February 09). Dow Corning to Present on Improving Compliance with Innovative Silicone-Based Drug Delivery Systems. AZoM. Retrieved on April 23, 2024 from https://www.azom.com/news.aspx?newsID=38574.

  • MLA

    Dow Corning. "Dow Corning to Present on Improving Compliance with Innovative Silicone-Based Drug Delivery Systems". AZoM. 23 April 2024. <https://www.azom.com/news.aspx?newsID=38574>.

  • Chicago

    Dow Corning. "Dow Corning to Present on Improving Compliance with Innovative Silicone-Based Drug Delivery Systems". AZoM. https://www.azom.com/news.aspx?newsID=38574. (accessed April 23, 2024).

  • Harvard

    Dow Corning. 2019. Dow Corning to Present on Improving Compliance with Innovative Silicone-Based Drug Delivery Systems. AZoM, viewed 23 April 2024, https://www.azom.com/news.aspx?newsID=38574.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.